3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
4
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Low Grade Serous Ovarian Carcinoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Leiomyosarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
HR+/HER2- Breast Cancer
1
Glioma
1
Interventions
Paclitaxel
12
Carboplatin
12
Bevacizumab
11
liposomal doxorubicin
8
Specimen Handling
8
olaparib
7
Magnetic Resonance Spectroscopy
7
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
mirvetuximab soravtansine
3
Taxes
3
Doxorubicin
3
sarilumab
2
niraparib
2
cemiplimab
2
cediranib
2
Immunoglobulin G
2
Disulfides
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
tocilizumab
1
sotorasib
1
peposertib
1
pelcitoclax
1
palbociclib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
abemaciclib
×
30 days
×
Clear all
No trials found.